Oakworth Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74K Buy
+50
New +$10.4K ﹤0.01% 700
2026
Q1
Sell
-75
Closed -$18.1K 875
2025
Q4
$18.1K Hold
75
﹤0.01% 578
2025
Q3
$20.5K Hold
75
﹤0.01% 556
2025
Q2
$19.4K Hold
75
﹤0.01% 448
2025
Q1
$16.8K Hold
75
﹤0.01% 476
2024
Q4
$17.2K Hold
75
﹤0.01% 477
2024
Q3
$18.3K Hold
75
﹤0.01% 459
2024
Q2
$14.4K Hold
75
﹤0.01% 457
2024
Q1
$14.9K Hold
75
﹤0.01% 434
2023
Q4
$12.9K Sell
75
-21
-22% -$3.23K ﹤0.01% 453
2023
Q3
$14.2K Hold
96
﹤0.01% 408
2023
Q2
$21K Hold
96
﹤0.01% 381
2023
Q1
$21K Hold
96
﹤0.01% 377
2022
Q4
$20K Buy
96
+21
+28% +$4.61K ﹤0.01% 364
2022
Q3
$16K Hold
75
﹤0.01% 402
2022
Q2
$16K Hold
75
﹤0.01% 404
2022
Q1
$18K Hold
75
﹤0.01% 396
2021
Q4
$20K Hold
75
﹤0.01% 420
2021
Q3
$20K Buy
+75
New +$20.5K ﹤0.01% 410

Other funds holding RMD

Oakworth Capital's RMD Position: Q2 2026 in Review

Oakworth Capital opened a new position in ResMed (RMD) in Q2 2026: 50 shares worth $9.74K. The stake represents ﹤0.01% of the portfolio and ranks #700 among its holdings. This is a return to the name: Oakworth Capital previously reported a position in RMD as recently as Q4 2025.

Oakworth Capital first reported a position in RMD in Q3 2021 and has held it in 19 quarters since. The position peaked at $21K in Q1 2023. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Oakworth Capital held 50 shares of ResMed worth $9.74K as of Q2 2026.
  • ResMed was a new Oakworth Capital position in Q2 2026.
  • ResMed made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #700 holding.
  • Oakworth Capital first reported a position in ResMed in Q3 2021 and has held it in 19 quarters since.
  • Oakworth Capital's ResMed position peaked at $21K in Q1 2023.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.